Frederik Flindt Kreiner (Frederik F Kreiner)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Cardiovascular Disease

Randomized Controlled Trial

Roux En Y Gastric Bypass

Top Venues

Expert review of clinical immunology

BMJ open diabetes research & care

This page only lists publications with an associated author ORCID identifier.

Publications

Frederik Flindt Kreiner, Bernt Johan von Scholten, Peter Kurtzhals, Stephen Charles Langford Gough
Glucagon-like peptide-1 receptor agonists to expand the healthy lifespan: Current and future potentials. Aging cell 22 (5) (2023)
Frederik Flindt Kreiner, Bernt Johan von Scholten, Peter Kurtzhals, Stephen Charles Langford Gough
Glucagon-like peptide-1 receptor agonists to expand the healthy lifespan: Current and future potentials. Aging cell 22 (5) (2023)
Frederik Flindt Kreiner, Philip Andreas Schytz, Hiddo J Lambers Heerspink, Bernt Johan von Scholten, Thomas Idorn
Obesity-Related Kidney Disease: Current Understanding and Future Perspectives. Biomedicines 11 (9) (2023)
Frederik Flindt Kreiner, Bernt Johan von Scholten, Peter Kurtzhals, Stephen Charles Langford Gough
Glucagon-like peptide-1 receptor agonists to expand the healthy lifespan: Current and future potentials. Aging cell 22 (5) (2023)
Stephen C Bain, Bendix Carstensen, Liselotte Hyveled, Stephanie Seremetis, Frederik Flindt Kreiner, Hanan Amadid, Alice Clark
Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study. BMJ open diabetes research & care 11 (3) (2023)
Frederik Flindt Kreiner, Jordan M Kraaijenhof, Matthias von Herrath, G Kees Kornelis Hovingh, Bernt Johan von Scholten
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives. Expert review of clinical immunology 18 (4) (2022)
Milan Geybels, Benjamin Ole Wolthers, Frederik Flindt Kreiner, Søren Rasmussen, Robert Bauer
Surrogate endpoint evaluation using data from one large global randomized controlled trial. BMC medical informatics and decision making 21 (1) (2021)